NERV
Minerva Neurosciences Inc
NASDAQ: NERV · HEALTHCARE · BIOTECHNOLOGY
$6.47
+1.25% today
Updated 2026-04-30
Market cap
$281.90M
P/E ratio
—
P/S ratio
1.87x
EPS (TTM)
$-34.67
Dividend yield
—
52W range
$1 – $9
Volume
0.3M
Minerva Neurosciences Inc (NERV) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-908543.00 | $-2.16M | $-35.96M | $-24.27M | $-25.69M | $3.09M | $-41.94M | $-43.43M | $-33.82M | $-24.60M | $-24.65M | $-14.78M | $-19.55M | $-13.51B |
| Capital expenditures | $0.00 | $3232.00 | $45609.00 | $52400.00 | $52400.00 | $52400.00 | $0.00 | $3.00 | $16326.00 | $16326.00 | $16326.00 | $2.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $587805.00 | $655723.00 | $17.97M | $2.20M | $3.57M | $5.03M | $8.18M | $9.17M | $9.70M | $5.22M | $4.11M | $1.97M | $1.33M | $1.33B |
| Free cash flow | $-908543.00 | $-2.16M | $-36.01M | $-24.32M | $-25.74M | $3.04M | $-41.94M | $-43.43M | $-33.84M | $-24.62M | $-24.66M | $-14.78M | $-19.55M | $-13.51B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $10.49M | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $16.73M | $-4.26M | $68.70M | $-56.93M | $24.20M | $-28.82M | $3.94M | — | — | — | — | — |